Oxford Biomedica (OXB)
- Share Price:
- 487.00p
- Market Cap:
- £589.49m
- Change Today:
-
-0.50p
- Sector:
- Pharma and Biotech
Oxford Biomedica reiterates outlook as interim losses narrow
By Abigail Townsend
Date: Tuesday 23 Sep 2025
LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica reiterated full-year guidance on Tuesday, after the biopharma saw strong demand throughout the first half and trimmed losses.
Revenues at the FTSE 250 firm, a specialist in cell and gene therapy, surged 44% to £73.2m in the six months to 30 June.
Half-year losses narrowed notably. Operating losses before interest, tax, depreciation and amortisation were £8.3m, down from £20.3m a year previously.
Frank Mathias, chief executive, said the first half had been driven by "sustained high demand" for its services.
He continued: "With our order book more than doubling year-on-year, and a strong revenue pipeline, we have good visibility on our growth trajectory and confidence in delivering our near and medium-term financial guidance."
In particular, he flagged a new loan facility secured during the first half. "This provides the financial flexibility to expand our global manufacturing capabilities in response to the demand we are seeing from clients," he said.
As a result, the group reiterated full-year guidance for revenues of between £160m and £170m, and operating EBITDA in low single-digit millions on a constant currency basis.
OXB Market Data
| Currency | UK Pounds |
| Price | 487.00p |
| Change Today | -0.50p |
| 52 Week High | 913.00p |
| 52 Week Low | 439.50p |
| Volume | 407,393 |
| Shares Issued | 121.04m |
| Market Cap | £589.49m |
Performance Indicators
- Value
-
- market
-
- full market star
- half market star
- empty market
- empty market
- empty market
-
- sector
-
- full sector star
- full sector star
- full sector star
- empty sector
- empty sector
- Price Trend
-
- market
-
- full market star
- full market star
- full market star
- full market star
- half market star
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- half sector star
- Income
- Not Available
- Growth
-
- market
-
- full market star
- full market star
- half market star
- empty market
- empty market
-
- sector
-
- full sector star
- full sector star
- empty sector
- empty sector
- empty sector
- Price Chg 6m
-
- market
-
- full market star
- full market star
- full market star
- full market star
- half market star
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- empty sector
- P/E
- Not Available
- PEG
-
- market
-
- full market star
- full market star
- full market star
- half market star
- empty market
-
- sector
-
- full sector star
- full sector star
- full sector star
- full sector star
- half sector star
- Dividend Yield
- Not Available
- EPS Growth
- Not Available